These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29187447)

  • 1. Analysis of Autoantibodies Related to Tumor Progression in Sera from Patients with High-grade Non-muscle-invasive Bladder Cancer.
    Minami S; Matsumoto K; Nagashio R; Hagiuda D; Fukuda E; Goshima N; Hattori M; Tsuchiya B; Hachimura K; Jiang SX; Saegusa M; Iwamura M; Sato Y
    Anticancer Res; 2017 Dec; 37(12):6705-6714. PubMed ID: 29187447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of tumor-associated antigens in culture supernatants using autoantibodies in sera from patients with bladder cancer.
    Minami S; Nagashio R; Ueda J; Matsumoto K; Goshima N; Hattori M; Hachimura K; Iwamura M; Sato Y
    Biomed Res; 2014; 35(1):25-35. PubMed ID: 24573199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.
    Ding W; Gou Y; Sun C; Xia G; Wang H; Chen Z; Tan J; Xu K; Qiang D
    Urol Oncol; 2014 Jan; 32(1):42.e13-9. PubMed ID: 24360660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low- and high-grade bladder cancer appraisal via serum-based proteomics approach.
    Bansal N; Gupta A; Sankhwar SN; Mahdi AA
    Clin Chim Acta; 2014 Sep; 436():97-103. PubMed ID: 24875752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray.
    Lee MS; Kim JH; Lee JS; Yun SJ; Kim WJ; Ahn H; Park J
    PLoS One; 2015; 10(4):e0125405. PubMed ID: 25915404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome-based classification of Nonmuscle Invasive Bladder Cancer.
    Stroggilos R; Mokou M; Latosinska A; Makridakis M; Lygirou V; Mavrogeorgis E; Drekolias D; Frantzi M; Mullen W; Fragkoulis C; Stasinopoulos K; Papadopoulos G; Stathouros G; Lazaris AC; Makrythanasis P; Ntoumas K; Mischak H; Zoidakis J; Vlahou A
    Int J Cancer; 2020 Jan; 146(1):281-294. PubMed ID: 31286493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and tissue profiling in bladder cancer combining protein and tissue arrays.
    Orenes-Piñero E; Barderas R; Rico D; Casal JI; Gonzalez-Pisano D; Navajo J; Algaba F; Piulats JM; Sanchez-Carbayo M
    J Proteome Res; 2010 Jan; 9(1):164-73. PubMed ID: 19883059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
    Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
    Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
    Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
    Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired estimated glomerular filtration rate is a significant predictor for non-muscle-invasive bladder cancer recurrence and progression--introducing a novel prognostic model for bladder cancer recurrence.
    Rausch S; Hennenlotter J; Todenhöfer T; Aufderklamm S; Schwentner C; Sievert KD; Stenzl A; Gakis G
    Urol Oncol; 2014 Nov; 32(8):1178-83. PubMed ID: 24962661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear cIAP1 overexpression is a tumor stage- and grade-independent predictor of poor prognosis in human bladder cancer patients.
    Che X; Yang D; Zong H; Wang J; Li X; Chen F; Chen X; Song X
    Urol Oncol; 2012; 30(4):450-6. PubMed ID: 21795072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
    Lin YL; Wang YL; Ma JG; Li WP
    J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.
    Yan C; Kim YW; Ha YS; Kim IY; Kim YJ; Yun SJ; Moon SK; Bae SC; Kim WJ
    J Surg Oncol; 2012 Mar; 105(4):425-30. PubMed ID: 22311819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation of p53 protein overexpression and p53 antibodies in serum of patients with transitional cell carcinoma of the urinary bladder.
    Wunderlich H; Hindermann W; Hüller M; Reichelt O; Werner W; Schubert J; Kosmehl H
    Urol Int; 2000; 64(1):13-7. PubMed ID: 10782026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer.
    Kitchen MO; Bryan RT; Haworth KE; Emes RD; Luscombe C; Gommersall L; Cheng KK; Zeegers MP; James ND; Devall AJ; Fryer AA; Farrell WE
    PLoS One; 2015; 10(9):e0137003. PubMed ID: 26332997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ΔNp63 expression is a protective factor of progression in clinical high grade T1 bladder cancer.
    Gaya JM; López-Martínez JM; Karni-Schmidt O; Bonal DM; Algaba F; Palou J; Villavicencio H; Benson MC; Cordon-Cardo C; Castillo-Martin M
    J Urol; 2015 Apr; 193(4):1144-50. PubMed ID: 25444981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer.
    Zhang X; Zhang Y; Liu X; Fang A; Wang J; Yang Y; Wang L; Du L; Wang C
    Oncotarget; 2016 Jan; 7(3):3255-66. PubMed ID: 26657502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of SAM68 in the progression and prognosis for bladder cancer.
    Zhang Z; Yu C; Li Y; Jiang L; Zhou F
    BMC Cancer; 2015 May; 15():364. PubMed ID: 25944080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of RING box protein-1 (RBX1) associated with poor prognosis of non-muscle-invasive bladder transitional cell carcinoma.
    Wang W; Qiu J; Liu Z; Zeng Y; Fan J; Liu Y; Guo Y
    J Surg Oncol; 2013 Jun; 107(7):758-61. PubMed ID: 23609182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.